ES538829A0 - Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida - Google Patents

Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida

Info

Publication number
ES538829A0
ES538829A0 ES538829A ES538829A ES538829A0 ES 538829 A0 ES538829 A0 ES 538829A0 ES 538829 A ES538829 A ES 538829A ES 538829 A ES538829 A ES 538829A ES 538829 A0 ES538829 A0 ES 538829A0
Authority
ES
Spain
Prior art keywords
pirimidincarboxamide
thiocarboxamide
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538829A
Other languages
English (en)
Other versions
ES8606296A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIROYAL Ltd
Uniroyal Inc
Original Assignee
UNIROYAL Ltd
Uniroyal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIROYAL Ltd, Uniroyal Inc filed Critical UNIROYAL Ltd
Publication of ES538829A0 publication Critical patent/ES538829A0/es
Publication of ES8606296A1 publication Critical patent/ES8606296A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES538829A 1983-12-19 1984-12-19 Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida Expired ES8606296A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US66520184A 1984-10-26 1984-10-26
US66526784A 1984-10-26 1984-10-26

Publications (2)

Publication Number Publication Date
ES538829A0 true ES538829A0 (es) 1986-04-16
ES8606296A1 ES8606296A1 (es) 1986-04-16

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538829A Expired ES8606296A1 (es) 1983-12-19 1984-12-19 Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida

Country Status (19)

Country Link
US (1) US4634707A (es)
JP (1) JPH0660164B2 (es)
AT (1) AT394194B (es)
AU (1) AU580746B2 (es)
BE (1) BE901301A (es)
CH (1) CH671225A5 (es)
DE (1) DE3446371A1 (es)
DK (1) DK164055C (es)
ES (1) ES8606296A1 (es)
FR (1) FR2557108B1 (es)
GB (1) GB2152047B (es)
GR (1) GR82494B (es)
IE (1) IE57675B1 (es)
IL (1) IL73840A (es)
IT (1) IT1213257B (es)
LU (1) LU85696A1 (es)
NL (1) NL8403856A (es)
NZ (2) NZ210599A (es)
SE (1) SE469171B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
GB2171099B (en) * 1985-02-15 1988-10-19 Ciba Geigy Ag 5-(azolyloxphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
AU7540991A (en) * 1990-03-09 1991-10-10 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
US6387914B2 (en) 2000-04-24 2002-05-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
WO2015123003A1 (en) * 2014-02-14 2015-08-20 Warrell Raymond P Bifunctional compounds and use for reducing uric acid levels
CN107108526A (zh) * 2015-01-22 2017-08-29 R·P·小沃勒尔 双功能化合物及用于降低尿酸水平的用途
TWI771303B (zh) 2016-06-30 2022-07-21 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(一)
DK3481819T3 (da) 2016-07-06 2022-07-25 Acquist Llc Forbindelser og anvendelse deraf til reducering af urisyreniveauer
IT201700028709A1 (it) 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
DE2962834D1 (en) * 1978-10-30 1982-07-01 Fujisawa Pharmaceutical Co 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
ZA849819B (en) * 1983-12-19 1985-07-31 Uniroyal Inc 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate

Also Published As

Publication number Publication date
GB2152047A (en) 1985-07-31
SE469171B (sv) 1993-05-24
DK164055C (da) 1992-09-28
ATA402684A (de) 1991-08-15
IE57675B1 (en) 1993-02-24
AU580746B2 (en) 1989-02-02
DK609184D0 (da) 1984-12-18
DK164055B (da) 1992-05-04
IL73840A (en) 1988-11-15
FR2557108A1 (fr) 1985-06-28
NZ210599A (en) 1987-09-30
JPH0660164B2 (ja) 1994-08-10
SE8406450D0 (sv) 1984-12-18
IE843237L (en) 1985-06-19
DE3446371A1 (de) 1985-06-27
AU3690884A (en) 1985-07-04
NL8403856A (nl) 1985-07-16
CH671225A5 (es) 1989-08-15
NZ220399A (en) 1987-09-30
FR2557108B1 (fr) 1988-11-18
GB8432112D0 (en) 1985-01-30
GR82494B (en) 1985-04-19
IT1213257B (it) 1989-12-14
IT8424104A0 (it) 1984-12-18
DK609184A (da) 1985-06-20
DE3446371C2 (es) 1990-08-16
GB2152047B (en) 1988-04-27
JPS62174058A (ja) 1987-07-30
IL73840A0 (en) 1985-03-31
SE8406450L (sv) 1985-06-20
AT394194B (de) 1992-02-10
US4634707A (en) 1987-01-06
LU85696A1 (fr) 1985-09-12
ES8606296A1 (es) 1986-04-16
BE901301A (fr) 1985-06-18

Similar Documents

Publication Publication Date Title
MX7539E (es) Procedimiento para la preparacion de una poliaminoalquenil o alquil succinimida modificada
ES533260A0 (es) Procedimiento para la preparacion de 13a-alquilgonanos
ES529171A0 (es) Un procedimiento para la preparacion de una cefalosporina.
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES538829A0 (es) Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida
ES499609A0 (es) Un procedimiento para la preparacion de una 3-yodometil-ce- falosporina
ES538621A0 (es) Procedimiento para la preparacion de fenolsulfonftaleinil-b-d-galactosidos
ES523156A0 (es) Un procedimiento para la preparacion de una 4-hidroxi-cumarina substituida con tetralilo
ES535625A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma
ES532572A0 (es) Procedimiento para la preparacion de n-piridilindoles
ES530081A0 (es) Un procedimiento para la preparacion de una macrolida
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES532957A0 (es) Procedimiento para la preparacion de sulfonilureas substituidas
ES532172A0 (es) Un procedimiento para la preparacion de derivados de pirimidona
MX156242A (es) Procedimiento para la preparacion de eter-sulfonatos
ES530973A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES544640A0 (es) Un procedimiento para la preparacion de una cefalosporina
ES535185A0 (es) Procedimiento para la preparacion de nuevas oxadiacinas
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES528114A0 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES530219A0 (es) Un procedimiento para la preparacion de una macrolida
ES535373A0 (es) Procedimiento para la preparacion de nuevas pirazolil- e isoxazolilsulfonilureas
ES531498A0 (es) Un procedimiento para la preparacion de derivados de pirimidinatriona
ES534480A0 (es) Procedimiento para la fabricacion de una pieza forjada

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503